158 related articles for article (PubMed ID: 26080906)
1. cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator.
Tinckam KJ; Liwski R; Pochinco D; Mousseau M; Grattan A; Nickerson P; Campbell P
Am J Transplant; 2015 Dec; 15(12):3194-201. PubMed ID: 26080906
[TBL] [Abstract][Full Text] [Related]
2. Application of calculated panel reactive antibody using HLA frequencies in Koreans.
Jang JY; Kim YJ; Kim Y; Park YJ; Han K; Oh EJ
Ann Lab Med; 2012 Jan; 32(1):66-72. PubMed ID: 22259781
[TBL] [Abstract][Full Text] [Related]
3. Establishment of calculated panel reactive antibody and its potential benefits in improving the kidney allocation strategy in Taiwan.
Shen SW; Chang CK; Gao YS; Hsu PJ; Cheng SC; Liu FY; Lo SC
J Formos Med Assoc; 2017 Dec; 116(12):956-963. PubMed ID: 29037453
[TBL] [Abstract][Full Text] [Related]
4. HLA-DQ barrier: effects on cPRA calculations.
Tambur AR; Leventhal JR; Walsh RC; Zitzner JR; Friedewald JJ
Transplantation; 2013 Dec; 96(12):1065-72. PubMed ID: 23995957
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.
Tambur AR; Audry B; Antoine C; Suberbielle C; Glotz D; Jacquelinet C
Am J Transplant; 2017 Dec; 17(12):3149-3158. PubMed ID: 28597555
[TBL] [Abstract][Full Text] [Related]
6. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
7. Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.
Karadeniz ST; Akgul SU; Ogret Y; Ciftci HS; Bayraktar A; Bakkaloglu H; Caliskan Y; Yelekci K; Turkmen A; Aydin AE; Oguz FS; Carin M; Aydin F
Transplant Proc; 2017 Apr; 49(3):445-447. PubMed ID: 28340809
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Changes in New Calculated Panel Reactive Antibody Adopting HLA-Cw, DR51/52/53, and DQ Antigens in Koreans.
In JW; Roh EY; Shin S; Park KU; Song EY
Transplant Proc; 2016 Apr; 48(3):766-9. PubMed ID: 27234731
[TBL] [Abstract][Full Text] [Related]
9. Portuguese calculated panel reactive antibodies online estimator.
Lima BA; Alves H
HLA; 2019 Jun; 93(6):445-450. PubMed ID: 30838808
[TBL] [Abstract][Full Text] [Related]
10. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry.
Duquesnoy RJ; Marrari M; Tambur AR; Mulder A; Sousa LC; da Silva AS; do Monte SJ
Hum Immunol; 2014 Nov; 75(11):1097-103. PubMed ID: 25305456
[TBL] [Abstract][Full Text] [Related]
11. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Iranian panel reactive antibody calculator and potential usefulness: A retrospective study.
Mohammadzadeh S; Jaladat AR; Mohammadi M; Geramizadeh B; Anbardar MH; Soleimani N; Amirinezhad Fard E; Tehrani NJ
Clin Transplant; 2022 Nov; 36(11):e14789. PubMed ID: 35933599
[TBL] [Abstract][Full Text] [Related]
13. HLA-DQ Mismatches Lead to More Unacceptable Antigens, Greater Sensitization, and Increased Disparities in Repeat Transplant Candidates.
Isaacson D; Schold JD; Gmeiner MW; Copley HC; Kosmoliaptsis V; Tambur AR
J Am Soc Nephrol; 2022 Dec; 33(12):2293-2305. PubMed ID: 36450598
[TBL] [Abstract][Full Text] [Related]
14. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
[TBL] [Abstract][Full Text] [Related]
15. Stem cell donor HLA typing improves CPRA in kidney allocation.
Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X; Maiers M; Kobashigawa JA; Gragert L
Am J Transplant; 2021 Jan; 21(1):138-147. PubMed ID: 32558252
[TBL] [Abstract][Full Text] [Related]
16. The DQ barrier: improving organ allocation equity using HLA-DQ information.
Tambur AR; Leventhal JR; Zitzner JR; Walsh RC; Friedewald JJ
Transplantation; 2013 Feb; 95(4):635-40. PubMed ID: 23288109
[TBL] [Abstract][Full Text] [Related]
17. [Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation].
Luo M; Yu L; Xiao L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):477-81. PubMed ID: 24752091
[TBL] [Abstract][Full Text] [Related]
18. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Schreuder GM; Hurley CK; Marsh SG; Lau M; Maiers M; Kollman C; Noreen HJ
Hum Immunol; 2001 Aug; 62(8):826-49. PubMed ID: 11476907
[TBL] [Abstract][Full Text] [Related]
19. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
[TBL] [Abstract][Full Text] [Related]
20. A simplified method of calculating cPRA for kidney allocation application in Hong Kong: a retrospective study.
Chan YP; Wong MWK; Tang LWM; Guo M; Yang W; Ip P; Li PKT; Leung CB; Chau KF; Lam JCK; Yeung NKM; Kwok JSY
Transpl Int; 2017 Dec; 30(12):1234-1242. PubMed ID: 28777478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
